Peer Reviewed, Contemporary, Authoritative
EpiSwitch is designed for men with prostate cancer risk in the UK and is 94% accurate. Oxford BioDynamics – a company developing precision medicine tests – has announced that its EpiSwitch Prostate Screening (PSE) blood test will be available to UK patients. The existing PSA test is 55% accurate and is considered an unreliable test […]
The post Oxford Biodynamics launches prostate screening test appeared first on International Pharmaceutical Industry.
Agreement with CSL Seqirus will provide a timely boost to pandemic preparedness against influenza. A deal has been made by the UK Health Security Agency (UKHSA) for millions of life-saving vaccines to be produced in the UK in the event of a future influenza pandemic. The ‘advance purchase agreement’ means healthcare company CSL Seqirus will […]
The post UKHSA reaches vaccine deal with CSL Seqirus appeared first on International Pharmaceutical Industry.
The trial involves the use of Padcev and Keytruda among patients with certain types of urothelial cancer. Seagen and Astellas have announced positive results from their phase 3 EV-302 clinical trial. The study involves Padcev – also known as enfortumab vedotin-ejfv – in combination with Keytruda (pembrolizumab) versus chemotherapy. The combination therapy has been used […]
The post Seagen and Astellas announce results from EV-302 study appeared first on International Pharmaceutical Industry.
The collaboration will utilise Evaxion’s EDEN-discovered antigen targets. Evaxion has announced that it has entered into a collaboration with Afrigen Biologics to develop an mRNA prophylactic vaccine against gonorrhoea. As part of the agreement, the Cape Town-based biotechnology company will utilise Evaxion’s EDEN-discovered gonorrhoea targets. Gonorrhoea is a sexually transmitted disease that stems from a […]
The post Evaxion and Afrigen Biologics to develop mRNA vaccine for gonorrhoea appeared first on International Pharmaceutical Industry.
IDAP aims to address the unmet clinical needs of patients and healthcare professionals. The UK government has announced the launch of the Innovative Devices Access Pathway (IDAP) to support the rapid development of innovative technologies. The new pathway aims to address the unmet clinical needs of patients and healthcare professionals. First announced in May, the […]
The post UK government launches pathway for innovative technologies appeared first on International Pharmaceutical Industry.
Leaders of the whole pharmaceutical value chain meet at the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) to find new connections and discuss trends in the industry. The Congress will be held on April, 22-23, 2024 in Amsterdam, the Netherlands. Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) is an annual networking event, that has a closed-door format: […]
The post Dive into the Pharmaceutical World with PHARMAP 2024 appeared first on International Pharmaceutical Industry.
(PHARMAP 2024) 22-23, April, 2024 Amsterdam, the Netherlands https://sh.bgs.group/yq The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) welcomes main representatives of the pharmaceutical industry, including top-level management, key technical manufacturing and packaging specialists, supply chain and procurement experts, and heads from manufacturing and packaging pharma technology companies. The Congress is set up to discuss challenges, […]
The post The Pharmaceutical Manufacturing and Packaging Congress 2024 appeared first on International Pharmaceutical Industry.
The platform identifies antigens to fight against bacterial infectious diseases. Evaxion Biotech has announced the validation of its artificial intelligence (AI)-powered vaccine discovery platform, Eden, marking a groundbreaking milestone in vaccine discovery. Evaxion is the first organisation to validate an AI model that outcompetes state-of-the-art vaccine development to combat antibiotic resistance. Infectious diseases are disorders […]
The post Evaxion validates its infectious disease AI vaccine platform appeared first on International Pharmaceutical Industry.
BeiGene will utilise Nona’s Harbour Mice platform as part of the agreement. BeiGene and Nona Biosciences have announced an agreement to expand their strategic collaboration for antibody discovery. The collaboration will allow BeiGene to utilise Nona’s Harbour Mice platform – a fully human transgenic mouse platform – to further improve therapeutic antibody discovery efficiency and […]
The post BeiGene and Nona Biosciences expand collaboration for antibody discovery appeared first on International Pharmaceutical Industry.
The treatment is the first oral GPCR receptor antagonist class recommended for NHS use. The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Vydura (rimegepant) as a cost-effective option for the treatment of acute migraines in adults. The recommendation marks Vydura as the first drug in the oral GPCR receptor antagonist class […]
The post Pfizer’s Vydura recommended by NICE for acute migraines appeared first on International Pharmaceutical Industry.
Buy me a coffee
Spenden / Donate